Trials / Completed
CompletedNCT04488978
Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension
A Randomized, Double-blind, Multicenter, Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypertension
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 440 (actual)
- Sponsor
- Handok Inc. · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-blind, Multicenter, Factorial Design, Phase II Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypertension
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Irbesartan/Amlodipine | QID |
Timeline
- Start date
- 2020-05-21
- Primary completion
- 2021-11-09
- Completion
- 2021-11-09
- First posted
- 2020-07-28
- Last updated
- 2022-06-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04488978. Inclusion in this directory is not an endorsement.